Kolon Life Science Inc. announced a private placement to issue 919,120 common shares at an issue price of KRW 21,760 per share for the gross proceeds of KRW 20,000,051,200 on June 13, 2024. The transaction will include participation from returning investor Kolon Corporation. The transaction has been approved by shareholders, restricted to a hold period and is expected to close on June 20, 2024.